-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, NGtH+WtUp1ekjONGYYiHQyKjtFbzQtgd9K6RGpTxySy+h4+fSsz515CHBGD8Ms3u 4nEmUgS+iiRCNcbmjsJQEA== 0001181431-04-013220.txt : 20040302 0001181431-04-013220.hdr.sgml : 20040302 20040302184222 ACCESSION NUMBER: 0001181431-04-013220 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20040227 FILED AS OF DATE: 20040302 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GENOME THERAPEUTICS CORP CENTRAL INDEX KEY: 0000356830 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 042297484 STATE OF INCORPORATION: MA FISCAL YEAR END: 0831 BUSINESS ADDRESS: STREET 1: 1OO BEAVER ST CITY: WALTHAM STATE: MA ZIP: 02453 BUSINESS PHONE: 7813982300 MAIL ADDRESS: STREET 1: 100 BEAVER STREET CITY: WALTHAM STATE: MA ZIP: 02453 FORMER COMPANY: FORMER CONFORMED NAME: COLLABORATIVE RESEARCH INC DATE OF NAME CHANGE: 19920703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SINGER DAVID B CENTRAL INDEX KEY: 0001240366 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-10824 FILM NUMBER: 04644080 MAIL ADDRESS: STREET 1: C/O GENESOFT PHARMACEUTICALS INC STREET 2: 7300 SHORELINE COURT CITY: S SAN FRANCISCO STATE: CA ZIP: 94080 4 1 rrd35257.xml X0201 4 2004-02-27 0 0000356830 GENOME THERAPEUTICS CORP GENE 0001240366 SINGER DAVID B 100 BEAVER STREET WALTHAM MA 02453 1 0 0 0 Stock Option (right to buy) 1.93 2004-02-27 4 A 0 223 6.42 A 2004-02-27 2014-02-27 Common Shares 223 1084457 D Compensation for attending board of directors meeting. Manny J. Bougoulas, Corporate Controller, Power of Atty 2004-03-01 -----END PRIVACY-ENHANCED MESSAGE-----